Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    9182212 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
Condition: Angioplasty, Transluminal, Percutaneous Coronary
Intervention: Drug: abciximab/low-dose weight-adjusted heparin; abciximab/standard-dose weight-adjusted heparin; placebo/standard-dose weight-adjusted heparin
2 Completed Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
Condition: Coronary Artery Disease
Interventions: Drug: Prasugrel;   Drug: Clopidogrel
3 Unknown  The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)
Conditions: Myocardial Infarction;   Coronary Artery Disease
Intervention: Procedure: coronary balloon-angioplasty with stenting

Indicates status has not been verified in more than two years